In this case study, Carl Brookes - vice president of Manufacturing & Supply Chain operations at Kindeva Drug Delivery & product commercialisation manager Francis Mackin explore what CDMOs should be doing to prepare for Brexit.
EPM speaks to Rafael Teixeira, President of logistics suppliers World Courier and ICS about the challenges of distributing a Covid-19 vaccine after approval.
Jeff Smythe, commercial development manager at Datwyler explains the importance of ensuring a robust parenteral packaging supply chain in unprecedented times.
Sukirti Kalra clinical project manager and Colin Newboul, head of Global Regulatory Affairs & Quality at Wasdell Group examine how clinical trials are adapting with the ongoing Covid-19 pandemic.
EPM speaks to Chris Ross, head of Life Science Integrated Supply Chain Operations at Merck to discuss the company's response to Covid-19 and the challenges in developing and supplying vaccines.
Jason Lacombe, CEO of software company Veratrak explains why the life sciences industry still needs to improve the way it manages data and the technologies that can help improve supply chains throughout pharma.
Abi Pesun, director at Almac ONE explains how a shift towards unified supply chain management can accelerate timelines and help mitigate risk for clinical trials during Covid-19.
EPM speaks to Alex Guite, vice president of Services and Alliances at World Courier about the impact Covid-19 has had on the clinical trials sector and how a direct-to-patient approach can help trials continue.
Nick Pike, chief revenue officer at Vizibl discusses why pharmaceutical companies aren't only interested in the financial benefits when it comes to collaboration.
Neal Singh, COO, Icertis, discusses how advancements in artificial intelligence (AI) are helping pharmaceutical manufacturers better manage their supply chains.
